To understand the function of the individual oncogenes of HPV16 in modulating the cellular response to apoptogenic signals, we used human keratinocytes immortalized with either E6, E7 or E6/E7 oncoproteins as model system. Applying CD95 antibodies or recombinant CD95 ligand, only the E7-immortalized cells underwent extensive apoptosis. In contrast, E6-and E6/E7-expressing keratinocytes were resistant. Dominance of E6 correlated with signi®cant down-regulation of p53, c-Myc, p21 and Bcl-2. CD95 was found to be reduced in resistant HPV-positive cells, while there were no quantitative dierences in expression levels of FADD, FLICE/caspase-8 or caspase-3. Notably, in contrast to primary human keratinocytes, all immortalized cells showed a general reduction of c-FLIP, an inhibitory protein which normally prevents unscheduled CD95-induced apoptosis. E6-and E6/E7-positive keratinocytes, however, can be sensitized to CD95 apoptosis by blocking proteasome-mediated proteolysis. CD95-resistant HPV-positive cells underwent apoptosis within 3 ± 5 h upon co-incubation with MG132 and agonistic antibodies or CD95 ligand, which was preceded by a strong re-expression of p53 and c-Myc, but not of other half-life controlled proteins such as Bax or IkBa. Blockage of proteasomal activity alone did not result in apoptosis, although the same set of pro-apoptotic proteins was up-regulated. Performing similar experiments with cervical carcinoma cells expressing mutated p53 (C33a) or with p53-`null' lung carcinoma cells (H1299), no CD95 cell killing occurred eventhough c-Myc was strong induced. These data indicate that the reduced bioavailability of p53 is a key-regulatory event in perturbation of CD95 signaling in HPV16 immortalized keratinocytes.
Introduction
Apoptosis or programmed cell death is implicated in a number of biological processes such as embryogenesis, immune system homeostasis and tumor regression (Evan and Littlewood, 1998, Jacobson et al., 1997; Winoto, 1997) . CD95/Fas/APO-1, a member of the tumor necrosis factor receptor superfamily (Itoh et al., 1991; Oehm et al., 1992) triggers apoptosis in many cell types. Binding of the CD95 ligand (CD95L) (Suda et al., 1993) or agonistic CD95 antibodies (Trauth et al., 1989) induce receptor oligomerization, recruitment of FADD (Fas-associated death domain) (Chinnaiyan et al., 1995) and FLICE/caspase-8 activation (Muzio et al., 1996) via the formation of a death-inducing signaling complex (DISC) (Kischkel et al., 1995) . Two dierent pathways for CD95-mediated apoptosis have been described (Scadi et al., 1998) : in type I cells, apoptosis is initiated by strong DISC formation leading to rapid activation of caspase-8 and caspase-3. In type II cells, DISC formation is reduced and the executioner procaspase-3 is activated by disruption of the mitochondrial membrane and the release of apoptogenic factors such as cytochrome c and Apaf-1 (Li et al., 1997) . Since type II cells depend on the mitochondrial branch, apoptosis can be blocked by ectopic overexpression of Bcl-XL or Bcl-2 . CD95-mediated apoptosis can also be modulated by FLICE/caspase-8-inhibitory proteins (FLIPs), which include both cellular and viral members thought to be involved in oncogenicity and viral persistence (for review, see Irmler et al., 1997; Thome et al., 1997) .
Apoptosis is also an important regulatory mechanism which counteracts uncontrolled growth of malignant cells (Evan and Littlewood, 1998) . In fact, as shown for cervical cancer, premalignant lesions exhibit reduced apoptotic indices of undierentiated basaloidlike cells, which correlates strongly with the probability of progression to squamous cell carcinomas (Nair et al., 1999; Sheets et al., 1996) .`High risk' human papillomavirus types (e.g. HPV16 and HPV18), which are causally involved in this disease (for review, see zur Hausen, 2000), encode two oncogenes, E6 and E7, capable of inducing immortalization of primary human keratinocytes (Barbosa and Schlegel, 1989; HawleyNelson et al., 1989) . E6 mediates p53 degradation (Schener et al., 1990) resulting in deregulated cell growth and enhanced genomic instability (Hartwell, 1992) . E7 binds and inactivates the anti-apoptotic retinoblastoma tumor suppressor protein (Rb), leading to the loss of G1 checkpoint control and activation of E2F-responsive S phase genes (Chellappan et al., 1992) .
Although modulation of apoptosis by HPV oncoproteins has already been reported, the results from these studies apparently depend on the cellular system, the viral type (Aguilar-Lemarroy et al., 2001) , the nature of the apoptotic stimulus and/or the cooperating oncogene. For example, HPV16 E6 blocks TNFmediated cytolysis in mouse ®broblasts (DuerksenHughes et al., 1999) , but can also sensitize immortalized human mammary epithelial cells and cultured human ®broblasts to apoptosis induced by tamoxifen treatment or DNA damaging agents (Brown et al., 1997; Seewaldt et al., 2001; Xu et al., 1995) . On the other hand, HPV16 E7 contributes to increased radioresistance of rat embryo ®broblasts co-transfected with mutant p53 and H-ras (Bristow et al., 1994) . Both HPV16 oncoproteins, however, enhance apoptosis in primary cervical epithelial cells when exposed under hypoxic conditions (Kim et al., 1997) , while E6/E7-positive keratinocytes were resistant against TNF-a/ cycloheximide (CHX) induced cytolysis (StoÈ ppler et al., 1998) . Nonetheless, E6/E7 expressing cervical carcinoma cells can still undergo apoptosis after treatment with chemotherapeutic drugs (Butz et al., 1996) , but these substances presumably circumvent the classical CD95 pathway, leading to receptor-independent caspase-8 and caspase-3 activation (Ferrari et al., 1998) . Although these studies unraveled a whole scenario of dierent mechanisms by which programmed cell death can occur, it is still unclear how HPV-positive cells react to physiological apoptotic stimuli.
In order to assess the eect of the individual oncoproteins of HPV16 on CD95-induced apoptosis in their natural target cells, E6-, E7-and E6/E7-immortalized human keratinocytes were exposed to agonistic CD95-antibodies (APO-1 Abs). In the present study we show that HPV16 E6 can negatively interfere with the commitment of E7-expressing cells to undergo CD95-mediated apoptosis by modulating the expression of p53, c-Myc, p21 and Bcl-2. Short-term blockage of p53 degradation in E6-and E6/E7-positive keratinocytes, by incubation with the proteasome inhibitor MG132, sensitizes HPV16-resistant cells to CD95-induced apoptosis. In contrast, p53-mutated C33a cervical carcinoma or p53`null' H1299 lung carcinoma cells were resistant to the combined MG132/ APO-1 Ab treatment although c-Myc was elevated. Hence, therapeutic strategies which selectively rescue the p53 pathway may help to sensitize HPV16 positive cells to CD95-mediated apoptosis, rendering them more susceptible to ecient immunological control.
Results

Expression of HPV 16 viral oncogenes in immortalized keratinocytes
To investigate the role of individual viral oncoproteins of HPV16 on CD95-mediated apoptosis, primary human foreskin keratinocytes were immortalized by amphotropic retroviruses carrying the viral oncogenes E6, E7 or E6/E7 (Whitaker and zur Hausen, unpublished). To avoid clonal variation, outgrowing cells were pooled and expanded for further studies. Mock infected primary keratinocytes underwent cellular senescence and died. In order to con®rm that the transduced viral genes were readily transcribed, RT ± PCR assays were performed. As shown in Figure 1a , the utilization of E7-speci®c primers lead to the detection of a 269 bp fragment present only in E6/ E7-and in E7-immortalized keratinocytes. Carrying out the same RT ± PCR in E6-expressing cells, E6-speci®c primer sets allowed the ampli®cation of two bands with 344 and 161 bp in size, corresponding to the complete and the spliced viral mRNAs encoding E6 and E6*, respectively (Doorbar et al., 1990) . The intensity of the accumulating bands demonstrates that both viral genes were expressed at similar steady state levels, although E6*-speci®c RNA was underrepresented in E6/E7 cells when compared with E6-positive keratinocytes (see Discussion).
E7 sensitizes keratinocytes to undergo apoptosis
To examine CD95-sensitivity, cells were exposed to APO-1 Ab (100 ng/ml) alone or in combination with sublethal doses of CHX (10 mg/ml) as sensitizer (Martin et al., 1990) . The extent of apoptosis was quanti®ed using an ELISA-based`Cell Death Detection' kit, which measured the amount of nucleosomal release into the cytoplasm after nuclear breakdown. As depicted in Figure 1b , HPV16 E7 expressing keratinocytes were very sensitive to APO-Ab/CHX treatment. However, keratinocytes immortalized by E6 revealed much lower levels of apoptosis, while E6/E7-immortalized keratinocytes and primary human keratinocytes were completely resistant under the same experimental conditions. Identical results were obtained using recombinant CD95L (data not shown), demonstrating equal speci®city and functionality of both inducers. TNF-a/CHX treatment, already shown to be enhanced in E7-immortalized keratinocytes (StoÈ ppler et al., 1998) , was less eective than APO-Ab/CHX application (Figure 1b) . Although CHX or actinomycin D was used in many studies to sensitize both TNF-a and CD95-mediated apoptosis (Schulze-Ostho et al., 1994) , we noticed that APO-1 Ab mediated apoptosis can also be enhanced by the simple addition of higher amounts of Staphylococcus aureus Protein A (PA) . The substitution of PA for CHX not only prevents non-speci®c eects after long-term inhibition of protein synthesis (Natoli et al., 1995) , but has also the advantage that shorter incubation periods were necessary to unmask potential additive or synergistic eects of reagents priming cells to undergo CD95-induced apoptosis. PA acts merely to increase the extracellular APO-1 IgG antibody aggregation via the Ig Fc domain (Langone, 1982) , but has itself no eect on apoptosis ( Figure 2a ) even after longer incubation (data not shown).
Using 5 mg/ml PA jointly with 100 ng/ml APO-1 Ab, E7-positive cells became apoptotic more rapidly than with APO-1/CHX (compare Figure 2a and 1b, respectively). Microscopic examination during time course experiments revealed distinct morphological alterations (e.g. blebbing in the membrane, cell rounding and shrinkage), which can be visualized already after 2 h, while the morphology of CD95-resistant cells remained largely unchanged. Only after incubation of at least 24 h, few apoptotic cells appeared in E6-immortalized cells, while E6/E7-expressing keratinocytes were still completely resistant (Figure 2b ).
E6 and E7 oncoproteins modulate the expression of pro-apoptotic proteins, but not components of the DISC We next addressed the question of whether dierences in CD95 sensitivity could be attributed to proteins known to be involved in the DISC formation. As demonstrated by Western blot analysis (Figure 3b ), neither FADD nor caspase-8 expression was signi®-cantly modulated. In addition, the amount of the downstream executioner caspase-3, controlling both cytoplasmic and nuclear events associated with CD95-mediated apoptosis (Zheng et al., 1998) , remained mainly unaltered. In contrast, the net amount of CD95-receptor gradually diminished in the order primary keratinocytes4E7-4E6-and E6/E7-positive Figure 1 HPV16 viral oncogene expression in immortalized human keratinocytes. (a) RT ± PCR products generated by E6/ E7 speci®c primer sets were separated on a 2% agarose gel. The position of the E6, E7 and E6* ampli®ed DNA fragments (344, 269, 161 bp, respectively) are indicated. 1 kb: size marker, 1 kb ladder. Non-Im: RNA from non-immortalized primary human keratinocytes used as control. (b) Quanti®cation of CD95/TNF-ainduced apoptosis using a`Cell Death Detection' ELISA kit. Abscissa: untreated control; treatment with 10 mg/ml CHX for 6 h; treatment with agonistic CD95 antibodies (APO-Ab, 100 ng/ ml); APO-Ab/CHX co-exposure; incubation with TNF-a (500 units/ml); TNF-a/CHX treatment. The enrichment factor (ordinate), for untreated control cells arbitrarily set at 1, directly re¯ects the extent of apoptosis in the respective cells. The graphs represent the average of three independent experiments, error bars are indicated Figure 2 Quanti®cation of apoptosis in normal and HPV16-immortalized keratinocytes. (a) Cells were treated either with Protein A (5 mg/ml) alone or in combination with APO-1 Ab (100 ng/ml). After 6 h, the extent of apoptosis was quanti®ed as described in Figure 1b . (b) Microscopic examination of HPV16-immortalized keratinocytes 2, 6 and 24 h after APO-1 Ab/Protein A treatment. Phase-contrast microscopy: magni®cation: 4006 cells ( Figure 3a) . However, the striking dierences in CD95 protein levels did not correlate with drastical changes of CD95 expression at the cell surface, since quanti®cation of the FACS pro®les revealed only less than a twofold higher amount of CD95 on E7-expressing cells in comparison with keratinocytes harboring the E6/E7 transcription cassette ( Figure  3c ). This suggests that the E6 oncoprotein of HPV16 can apparently perturb CD95 sensitivity in immortalized keratinocytes without aecting the DISC components.
In order to determine the role of apoptosismodulating proteins, we subsequently screened the steady-state levels of p53, p21, Rb, c-Myc, Bcl-2, Bcl-XL, Bax and c-FLIP by Western blot analysis ( Figure  4 ). As expected, the presence of HPV16 E6 resulted in a strong reduction of p53 via ubiquitin-dependent proteolysis (Schener et al., 1990) , whereas the p53 levels in primary and E7-immortalized keratinocytes were similar. Parallel to the E6-mediated reduction of p53, the levels of p21 were also decreased. Although it has been reported that HPV16 E7 can promote Rb degradation (Boyer et al., 1996) , the amount of Rb was not signi®cantly altered. Conversely, high levels of the pro-apoptotic protein c-Myc were detected both in primary and E7-immortalized keratinocytes, whereas cMyc expression was drastically diminished in CD95- ourescence intensities (=extent of CD95 expression). The quanti®ed geometrical mean levels of¯ourescence are given Figure 4 Western blot analyses of proteins involved in apoptosis. Total cellular extracts (50 mg protein/lane) of each cell line were loaded in triplicate and electrophoresed in three identical 12% SDS ± PAGE gels. After electrotransfer, the ®lters were consecutively incubated overnight at 48C with antibodies against p53, p21, Rb, c-Myc, Bcl-2, Bcl-XL, Bax and c-FLIP. Equal loading was con®rmed by incubating ®lters with an actin-speci®c antibody. The molecular weights are indicated in kilodaltons (kDa) resistant HPV-positive cells. This is consistent with the notion that E6 also controls the half-life of c-Myc by the ubiquitin pathway (Gross-Mesilaty et al., 1998) .
Another class of molecules that negatively regulates apoptosis is represented by the Bcl-2 protein family (Reed, 1998) . Contrary to our expectations, Bcl-2 levels were highest in sensitive E7 cells, while Bcl-2 was barely detectable in the resistant HPV 16-positive counterparts (Figure 4 ). Bcl-XL was similarly expressed in all cell lines, except in E6-containing cells, where the amount of Bcl-XL was slightly diminished. Additionally, the pro-apoptotic Bax protein, which is p53 responsive under certain conditions (Korsmeyer, 1999) was expressed in approximately twofold lower amounts in E6-positive cells when compared with E7-expressing cells and primary keratinocytes. Although the latter cells share the same expression pattern of pro-and anti-apoptotic proteins, they behaved completely dierent in their response to CD95 signaling (Figures 1b and 2a) . To resolve this apparent discrepancy, we monitored the expression of the FLICE/Caspase-8 inhibitory protein c-FLIP, which normally prevents uncontrolled apoptosis by interfering with CD95 DISC formation (Irmler et al., 1997; Thome et al., 1997) . Notably, as depicted in Figure 4 , c-FLIP was only expressed in primary keratinocytes, but was almost completely down-regulated in all of the immortalized cell lines. Considering these data with respect to functionality, it was hypothesized that both p53 and c-Myc could be the prime candidates accounting for dierential sensitivity towards CD95-mediated apoptosis.
Proteosomal inhibition sensitizes E6-and E6/E7-expressing keratinocytes to CD95-mediated apoptosis by functional reactivation of p53
The metabolic half-life of p53 and c-Myc are both controlled by E6 and a cellular factor termed E6-AP (Schener et al., 1994; Gross-Mesilaty et al., 1998) . These proteins form a trimeric compound, promoting ubiquitination and subsequent degradation via the large multicatalytic proteasomal complex (for review, see Rolfe et al., 1997) . In order to test whether restoration of pro-apoptotic proteins can be functionally linked to CD95-sensitivity, resistant cells were incubated with the proteasome inhibitor MG132 (Drexler, 1997) . Western blot analysis revealed accumulation of both c-Myc and p53 within 1 h of 20 mM MG132 treatment which were not further augmented independently of whether the cells were treated for 3 or 5 h (Figure 5a ). The kinetics of p53/cMyc stabilization seems to be selective, because the amount of IkBa and Bax, also known to be controlled by the proteosomal pathway (Lee and Goldberg, 1998; Li and Dou, 2000) was unchanged. Note that the expression of Mad1, an anti-apoptotic protein which can antagonize the c-Myc transcriptional/apoptotic function (Gehring et al., 2000) was also not aected. Finally, incubations of identical ®lters with a monoclonal actin antibody con®rmed equal loading and Figure 5a , the delayed induction of the cyclin-dependent kinase inhibitory protein p21WAF/Cip1 (p21) followed the same kinetics as shown for the corresponding mRNA (Figure 5b ). p21 accumulation, therefore, appeared to be more the consequence of transcriptional upregulation on RNA level due to p53 reactivation rather then by extension of its metabolic half-lfe on protein level after MG132 treatment. On the contrary, for the two other p53-responsive genes, namely CD95 (MuÈ ller et al., 1998) and Bax (Miyashita et al., 1994) , no p53-induced transcriptional activation was apparent ( Figure 5B ). Although CD95 transcription was not directly up-regulated upon p53 reactivation, there still exist the chance that surface expression could be increased through a p53-dependent post-translational mechanism which enhances CD95 transport from cytoplasmic stores (Bennett et al., 1998) . However, the FACS pro®les of treated and control E6-expressing cells were nearly identical, excluding the possibility that the sensitization was due to intracellular recompartmentalization of CD95 (data not shown).
To test whether or not half-life rescue of p53/c-Myc alone was sucient to induce apoptosis, E6-and E6/ E7-expressing keratinocytes were incubated with MG132 alone or in combination with APO-1 Abs and subsequently assayed with an ELISA-based`Cell Death Detection' kit. As summarized in Figure 6 , only the simultaneous incubation of MG132 with the APO-1 Abs induced signi®cant cell death, discernible within 3 h of treatment. Longer incubation of up to 5 h lead to apoptotic enrichment factors ranging between 14 and 20, which corresponded to approximately 90% dead cells, when measured in a dimethylthiazoldiphenyl tetrazolium bromide (MTT) cytotoxicity assay (data not shown).
Cells lacking functional p53 cannot be sensitized to CD95-mediated apoptosis by MG132
Since MG132 treatment may block a whole variety of important short-lived regulatory proteins and to discriminate between the sensitizing function of cMyc and p53, cells with impaired p53 capacity were examined. Monitoring either the cervical carcinoma cell line C33a or the lung carcinoma cell line H1299 (Mitsudomi et al., 1992) under the same experimental conditions, both cell types were completely resistant against CD95-mediated apoptosis, independent of their exposure to MG132 alone or in combination with APO-1 Ab (Figure 7a ). While C33a cells harbor a mutated p53 (Schener et al., 1991) , H1299 cells completely lack detectable p53 protein when assayed by Western blot analyses (Figure 7b ). MG132 treatment, however, led to the same strong increase of c- Total cellular extracts (50 mg protein/lane) of each cell line were separated on a 12% SDS ± PAGE gel. After electrotransfer, the ®lters were incubated with antibodies against p53, cMyc, Bax and IkBa. Equal loading was con®rmed by using an anti-actin antibody Figure 6 Induction of apoptosis in E6-and E6/E7 immortalized keratinocytes after APO-Ab/MG132 co-incubation for dierent periods of time. Quanti®cation of the extent of apoptosis using à Cell Death Detection' ELISA kit. Cells were treated for 1, 3 or 5 h with MG132 (20 mM) alone or in combination with APO-Ab (100 ng/ml). The enrichment factor (ordinate), for untreated control cells arbitrarily set at 1, directly re¯ects the extent of apoptosis in the respective cells. The graphs represent the average of three independent experiments, error bars are indicated Myc as previously observed in E6 and E6/E7-positive keratinocytes (Figure 5a ), but again without aecting Bax or IkBa (Figure 7b ). The absence of apoptosis, despite a time-dependent elevation of c-Myc strongly supports the notion that E6-mediated degradation of p53 in fact represents the major key-regulatory process, which interferes with CD95-engaged apoptosis in HPV16-immortalized human keratinocytes.
Discussion
Our previous study has shown that human papillomavirus type 16, the most prevalent HPV type found in cervical cancer (zur Hausen, 2000) , can selectively counteract CD95-mediated apoptosis (Aguilar-Lemarroy et al., 2001). It was therefore of major interest to unravel the role of the individual oncogenes E6 and E7 of HPV16 on CD95-induced apoptotic death in human keratinocytes, which are the natural target cells of viral infection (Iftner et al., 1992) . For this purpose, primary human foreskin keratinocytes were used as recipients for retroviral gene delivery of individual HPV16 oncogenes. As shown in Figure 1a , all three cell lines express the viral genes with equal eciency, which was an important prerequisite to utilize these cells as experimental model system, because viral gene dosage eects on the commitment to undergo apoptosis can be excluded.
Incubation of HPV16-immortalized cells with APO-1 Ab in the presence of cycloheximide revealed that E7-positive keratinocytes had become susceptible to apoptosis, whereas keratinocytes immortalized with the E6/E7 genes or primary non-immortalized cells remained resistant (Figure 1b) . However, E6-expressing keratinocytes were slightly susceptible. Notably, as shown by RT ± PCR analysis (Figure 1a ), these cells express higher levels of E6* than E6/E7-immortalized cells. Whether this property correlates with the ability of E6* to favor apoptosis via interference with E6-directed degradation of p53 (Pim and Banks 1999) remains to be elucidated. Furthermore, HPV16 E7-expressing keratinocytes displayed higher sensitivity to APO-Ab/CHX than after TNF-a/CHX application (StoÈ ppler et al., 1998) . This indicates that the removal of pre-existing cellular factors, by de novo protein synthesis abrogation, facilitates CD95-induced apoptosis more than the TNF-mediated cytolysis. This is in agreement with the ®nding that, although structurally related, CD95 and TNF receptor used distinct signal transduction pathways to induce cell killing (SchulzeOstho et al., 1994 ).
An interesting cross-talk between p53 and the CD95 pathway became evident, when it was noticed that CD95 expression can be stimulated by p53 via a p53-responsive element within the promoter and ®rst intron region of the gene both under physiological (OwenSchaub et al., 1995) and pathophysiological conditions (MuÈ ller et al., 1998) . Since the amount of the proapoptotic protein p53 was severely reduced both in E6-and E6/E7-positive cells (Figure 4) , it was expected that the attenuation of p53 function by ternary complex formation with E6-AP and subsequent proteasomal degradation (Schener et al., 1990; Talis et al., 1998) should have a negative eect on the net amount of CD95 at the cell surface and, in turn, on signal transduction. However, E6 appears to signi®-cantly dysregulate neither CD95 surface expression (Figure 3c ) nor that of other intracellular components of the DISC, since the levels of both FADD and procaspase-8 were not in¯uenced (Figure 3b ). This contrasts with data obtained using chemotherapeutical drugs (e.g. adriamycin or cisplatin) which consistently lead to up-regulation of CD95 upon p53 induction (MuÈ ller et al., 1998) , at least in certain cell systems. Although it has been reported that p53 can induce Bax and suppress Bcl-2 under distinct experimental conditions (Miyashita et al., 1994) , their expression levels also did not correlate with acquisition of a CD95 sensitive phenotype in HPV-positive cells. Both Bcl-2 and Bcl-XL were even higher expressed in CD95 sensitive E7-cells than in their resistant E6 and E6/E7 counterparts lacking sucient amounts of functional p53 (Figure 4) . The pro-apoptotic protein Bax was approximately twofold elevated in CD95-sensitive E7-cells, consistent with the fact that Bax is a p53 responsive gene (Oltvai et al., 1993) . However, these dierences did not account for the commitment to undergo apoptosis, because Bax not became upregulated after sensitization of CD95 resistant HPVpositive cells (see below). Moreover, studies in mice with a defective Bax gene have shown that Bax, like p21, is dispensible for apoptosis (Deng et al., 1995; Knudson et al., 1995) . Because the levels of p53 and cMyc, whose half-life and bioavailability are both controlled by E6-mediated degradation via the proteasome (Schener et al., 1993; Gross-Mesilaty et al., 1998) varied so tremendous between CD95 resistant and sensitive cells, we reasoned that these molecules may represent the key players in the commitment to undergo CD95-mediated apoptosis.
However, elevated levels of c-Myc and p53 alone were not sucient to render primary human keratinocytes susceptible to apoptosis after antibody addition (see Figure 1b) . CD95-mediated cell killing can also be modulated by the FLICE/Caspase-8 inhibitory protein c-FLIP (Irmler et al., 1997; Thome et al., 1997) . c-FLIP expression apparently ensures that normal cells (e.g. untransformed primary keratinocytes) fail to undergo apoptosis (Leverkus et al., 2000) under conditions where the cell cycle and dierentiation/ senescence program is not perturbed (Chaturvedi et al., 1999) . Therefore, high levels of c-FLIP, which interfere with DISC formation by preventing caspase-8 recruitment (Scadi et al., 1999) could only be found in primary keratinocytes, whereas the protein was generally down-regulated in all immortalized cells in the order E7/E64E74E6 (Figure 4) . Conversely, despite the fact that c-FLIP was reduced in E6-positive cells, no apoptosis was induced in those cells because the pro-apoptotic proteins, c-Myc and p53, were missing (Figure 4) .
To test the assumption that c-Myc and/or p53 are involved in the outcome of the apoptotic response, E6-and E6/E7-expressing cells were treated with MG132, a leupeptin analog that decreases degradation of ubiquitin-conjugated proteins by the 26S proteasome complex without aecting its ATPase or isopeptidase activity (Rolfe et al., 1997) . The availability of inhibitors such as MG132 allows the analysis of short-lived proteins directly in living cells and their contribution to apoptosis. Since longer inhibition of proteolysis can nonspeci®cally trigger apoptosis in certain cellular systems (Meriin et al., 1998) , CD95-resistant keratinocytes were only incubated for a brief period of time (between 1 and 5 h). As shown in Figure 5a , saturated levels of both p53 and c-Myc can be already visualized 1 h after MG132 treatment. Half-life stabilization of both proteins was selective, since the net amount of IkB-a and Bax, also known to be degraded by the proteosomal pathway (Lee and Goldberg, 1998; Li and Dou, 2000) was unaected even after longer treatment. Although the intracellular level of the cyclin-dependent kinase inhibitory protein p21 WAF/Cip1 is also controlled by the proteasomal complex (Maki et al., 1996) , the delayed induction (after 3 h of MG132 addition, see Figure 5a ) was probably linked to functional p53 reactivation, since the appearance of both p21 mRNA and protein followed roughly the same kinetics ( Figure  5b ). Hence, p53 retained the ability to induce p21 (El Deiry et al., 1994) , but failed to trans-activate other responsive genes such as CD95 (MuÈ ller et al., 1998) or Bax (Miyashita et al., 1994) . Nevertheless, accumulation of p53 and c-Myc alone did not ultimately results in cell death, but obviously primed E6 and E6/E7-expressing cells for CD95 apoptosis, which can ®nally be exerted upon the addition of APO-1 Ab.
In order to discriminate between the pro-apoptotic capacity of c-Myc and p53 and to exclude the involvement other unknown short-lived proteins engaged in MG132/Apo-Ab induced apoptosis, two cell lines with impaired p53 function were examined. C33a cells represent a HPV-negative cervical carcinoma cell line harboring a p53 mutation at codon 273, resulting in an amino acid exchange of Arg ? Cys. Since C33a cells additionally contain a genomic mutation of the pRb gene in the exon 20 splice acceptor (Schener et al., 1991) which may aect its anti-apoptotic function (Haas-Kogan et al., 1995) and the outcome of our results, we further used a lung cell carcinoma line (H1299) lacking p53 due to a homozygous 5'-intragenic deletion (Mitsudomi et al., 1992) . Experiments carried out with these cells revealed that even though c-Myc protein levels increased, no eect on cell survival after CD95 antibody addition could be demonstrated. This is in contrast to the observation made in rodent cells, where Rat1 ®broblasts were not susceptible to killing by CD95 ligand unless c-Myc was expressed (for review, see Prendergast, 1999) .
On the other hand, it was not possible to rescue CD95 resistant cells by overexpression of dominantnegative p53 mutants in E6 or E6/E7-positive keratinocytes after MG132/Apo-Ab co-incubation (data not shown). Inactivation of wild-type p53 by certain dominant-negative mutants may depend on several factors: the wild-type to mutant ratio within the heterodimers, the conformation of the mutant protein, the anity for DNA (CheÂ ne, 1998) and the cellular context where E6 is expressed (Hengstermann et al., 1998) . To circumvent at least some of these problems (e. g. the relative intracellular dosage of mutant p53), we are currently trying to establish somatic cell hybrids between E6-immortalized keratinocytes and C33a cells for MG132/Apo Ab challenge, since the latter express extremely high amounts of mutated p53 (Figure 6 ), when compared with other cell types containing wt p53 (Schener et al., 1991; Liang et al., 1993) . In this context, it is also important to stress that wt p53 delivery via adenovirus vectors in H1299`null' p53 cells strongly enhance CD95 receptor/ligand interaction. Application of CD95/ligand blocking antibodies impairs apoptosis, clearly indicating that re-expression of wild-type p53 enhances CD95 signaling (Fukazawa et al., 1999) .
Hence, induction of apoptosis after MG132/APO-1 Ab co-incubation appears to be more the result of p53 rather than c-Myc reactivation, whereby the mere quantitative accumulation of p53 was apparently still not sucient to trigger the complete biological response (see Figure 6 ). This indicates that, either an alternative p53-dependent pathway exists which leads to apoptosis without requiring the activation of speci®c target genes such as CD95 or Bax, or that p53 becomes post-translationally modi®ed after APO-1 Ab addition. Indeed, recent reports suggest that dierent treatments cause distinct phosphorylations of p53 which in turn, may activate alternative sets of genes causing either growth arrest or apoptosis (Kobayashi et al., 1998; Oda et al., 2000) . It will be an important question in further experiments to examine the phosphorylation pattern of p53 at dierent times after CD95L or APO-1 Ab application.
In conclusion, our data show that CD95 resistant HPV-positive cells can be completely sensitized to CD95-mediated apoptosis after short-term blockage of the ubiquitin-proteasome system. Hence, experimental approaches based on functional reactivation of p53 by selectively inhibiting this pathway may help the immune system to eradicate premalignant and tumorigenic HPV-infected cells by CD95-induced apoptosis.
Materials and methods
Cell culture
Primary human keratinocytes derived from adult skin and foreskins of 4 ± 5 year-old donors were immortalized with E6, E7 or E6/E7 oncogenes of HPV16 after infection with amphotropic retroviruses (Halbert et al., 1991; Whitaker and zur Hausen, unpublished) . All cell lines as well as the primary human keratinocytes were grown in`Keratinocyte Growth Medium' (PromoCell). C33a (Yee et al., 1985) and H1299 (Mitsudomi et al., 1992) cells were maintained in Dulbecco's modi®ed Eagle's medium (DMEM) (SIGMA) containing 10% fetal calf serum (GIBCO), penicillin (100 U/ml) and streptomycin (100 mg/ml) (SIGMA).
CD95L, APO-1 Ab and TNF-a/cycloheximide (CHX) treatment
2610
6 cells were plated in 10 cm Petri dishes. Next day, cells were treated with 100 ng/ml of APO-1 Ab (Trauth et al., 1989) , 25 ng/ml recombinant CD95 ligand (CD95L) in the presence of 1.5 mg/ml`potentiator' (UBI-Upstate Biotechnology) or with TNF-a (500 U/ml, Strathmann Biotech GmbH) either alone or in the presence of 10 mg/ml CHX (Sigma). The eciency of APO-1 Ab induced apoptosis was increased by the addition of 5 mg/ml protein A (Sigma) . MG132 (Calbiochem) was dissolved in DMSO to a concentration of 20 mM.
Quantification of apoptosis
The extent of apoptosis was determined with the Cell Death Detection ELISA PLUS Kit (Roche Diagnostics, Mannheim) following the manufacturer instructions. The absorbance of the samples was determined in a Microplate Reader at 405 nm. The enrichment factor was calculated by dividing the absorbance of the treated sample by the absorbance of the control cells.
Detection of CD95 by FACS analysis
1610
6 cells were seeded in 10 cm Petri dishes. Next day, cells were scrapped, resuspended in 100 ml DMEM containing 2 mg/ml of APO-1 Ab and incubated on ice for 1 h. After centrifugation and washing with PBS, cell pellets were resuspended in 100 ml PBS containing 20 mg/ml anti-mouse conjugated FITC antibody (Vector Laboratories) for an additional hour on ice. After washing with PBS, cells were analysed for 10 000 single events in a Becton Dickinson¯ow cytometer using the FITC detection ®lter FL1 (515 ± 545 nm) and the`Cell Quest' software for analysis. As a control, cells were incubated with an isotype non-speci®c antibody (FII23) as described (von Reyher et al., 1998) . The geometrical mean displayed in the ®gure legends was calculated by subtracting the values of the isotype control from the values of the CD95 treated cells.
RT ± PCR
Reverse transcriptase reaction (20 ml ®nal volume) was performed with 1.5 mg of total RNA following exactly thè SuperScript TM II protocol' described in the attached instructions (Gibco BRL). The PCR reaction was carried out in a ®nal reaction volume of 50 ml, which was supplemented with: 2.5 U Taq DNA polymerase (Sigma), 16PCR Buer (Sigma), 2.5 mM MgCl 2 (Sigma), 200 mM dNTP Mix (Roche Diagnostics, Mannheim), 300 nM of each primer and 1.5 ml of the RT reaction. Primers for E6 detection: upper primer 5'-ACT GCA ATG TTT CAG GAC CC-3', lower primer 5'-TCA GGA CAC AGT GGC TTT TG-3'; for E7 detection: upper primer 5'-CCC AGC TGT AAT CAT GCA TG-3', lower primer 5'-TGC CCA TTA ACA GGT CTT CC-3'. PCR conditions for both sets of primers: initial denaturation time of 3 min at 948C, 30 s at 948C, 1 min at 608C, 1 min at 728C (35 cycles) and 10 min at 728C. Primers for GAPDH (Griths et al., 1997) : upper primer 5'-TGG ATA TTG TTG CCA TCA ATG ACC-3'; lower primer 5'-GAT GGC ATG GAC TGT GGT CAT G-3'. The condition for PCR: initial denaturation for 3 min at 948C, 30 s at 948C, 45 s at 658C, 30 s at 728C (35 cycles) and 10 min at 728C. After PCR, 20 ml of each reaction were loaded on a 2% ethidium bromide agarose gel.
Northern blot analysis
Total cellular RNA was isolated using RNeasy kit (QIA-GEN) as described in the manufacturer instructions. Five mg RNA was separated in 16MOPS/1% agarose gels in the presence of ethidium bromide under non-denaturating conditions (Khandjian and Meric, 1986 ) and transferred to Gene Screen plus membranes (DUPONT). Plasmids containing the cDNA of CD95 receptor (pBS-APO14.2) (Behrmann et al., 1994) , p21 (El Deiry et al., 1993) , Bax (Oltvai et al., 1993) and GAPDH (obtained from Dr H Rahmsdorf, Karlsruhe) were labeled by random priming. Hybridization was carried out at 428C in the presence of 50% formamide. The ®lters were washed three times for 10 min with 26SSC/ 0.1% SDS at 688C.
Western blot analyses of apoptosis related proteins
Total cellular protein extracts were prepared using ice cold RIPA buer (0.5% deoxycholate, 0.5% NP-40, 0.5% SDS, 50 mM Tris pH 7.4 and 100 mM NaCl) supplemented with freshly added protease inhibitor cocktail (Complete TM , Roche Diagnostics, Mannheim). Fifty mg of total protein were electrophoresed on 12% SDS-polyacrylamide gel, electrotransferred to Immobilon TM -P PVDF membranes (Millipore Corporation) and probed with antibodies as described (Aguilar-Lemarroy et al., 2001) .
Antibodies
The antibodies used in this study were: CD95 (sc-715; Santa Cruz, Inc.); FADD (F36620, Transduction Laboratories), Caspase-3 (C31720, Transduction Laboratories), Bcl-XL (B22630, Transduction Laboratories), Rb (600048; LoxoNovocastra), p53 (sc-126; Santa Cruz, Inc.), p21 (C24420, Transduction Laboratories), Mad1 (65396E, PharMingen), cMyc (14851A, PharMingen), Bcl-2 (1624989, Roche Diagnostics), Bax (13666E, PharMingen), IkBa (sc-371, Santa Cruz), Caspase-8 , c-FLIP (NF6) (Scadi et al., 1999) , PARP (Kaufmann et al., 1993) and actin (ICN Biomedicals).
